United States of America v. Exactech Inc

District Court, N.D. Alabama·Decided September 8, 2022·No. 7:18-cv-01010·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ALABAMA SOUTHERN DIVISION

UNITED STATES OF )

AMERICA, et al., ex rel. ) BROOKS WALLACE, ) ROBERT FARLEY and )

MANUEL FUENTES, et al. ) ) 2:18-cv-01010-LSC Plaintiffs, )

vs. ) ) EXACTECH, INC., )

Defendants. )

Memorandum of Opinion and Order I. BACKGROUND AND LEGAL STANDARD Before this Court is Defendant Exactech’s Rule 59(e) Motion for Reconsideration (Doc. 189) of this Court’s Memorandum of Opinion and Order (Doc. 184) denying their previous Motion for Summary Judgment (Doc. 143) and Motion to Dismiss (Doc. 161).1 II. DISCUSSION Exactech’s Rule 59(e) motion primarily proffers two arguments. The Court addresses each in turn.

1 A comprehensive factual summary of this case is contained in that opinion. (Doc. 184). A. Whether the Public-Disclosure Bar Applies Exactech’s first argument involves the Court’s previous determination that

the FCA’s public-disclosure bar did not apply in this case because it failed the second prong of Cooper. (See Memorandum Op., Doc. 184 at 12-13). Even if the

Court’s reasoning is flawed, the decision to deny Exactech’s Motion to Dismiss was nevertheless proper because Relators satisfy the original-source exception.

The public-disclosure bar attempts to strike a balance between the FCA’s goals of encouraging people with inside information to expose fraud against the government and avoiding parasitic suits brought by people that played no role in

bringing fraud to light. See U.S. ex rel. Williams v. NEC Corp., 931 F.2d 1493, 1497 (11th Cir. 1991). In other words, the purpose of the public-disclosure bar is to differentiate between whistleblowers and freeloaders. It functions by barring qui

tam actions based on publicly disclosed information, unless the relator bringing that action is the original source of said information. See U.S. ex rel. Osheroff v. Humana Inc., 776 F.3d 805, 812 (11th Cir. 2015). A relator is an original source if their

knowledge was “direct and independent” of the publicly disclosed information. Id. at 814. A relator is not an original source if their knowledge was mere “background information which enable[d] him to understand the significance of a more general

public disclosure.” Id. at 815. Exactech claims multiple instances of overlapping facts between this action and the previous products liability suits filed by Cory Watson trigger the public

disclosure bar. For example, Exactech cites to the fact that Relators in this qui tam action pleaded in their complaint: “In early 2008. . . Exactech had definitive

knowledge that the [Device] was defective.” (Doc. 1 at 19). Similarly, the complaint filed by one of five plaintiffs in the products liability suits alleged: “By at least April 2008, [Exactech] became aware of a high rate of early failures with the

[Device].” (Doc. 160, Ex. A at 26). The parties agree that, because the Cory Watson lawsuits were filed before

this qui tam action, Exactech’s awareness of the Device’s defect was publicly disclosed information. Exactech argues that because that allegation is central to this qui tam action, the Relators’ claims were based on that publicly disclosed

information. But even if the Court accepted that argument, the public-disclosure bar would still not apply in this case if the Relators were the original source of that publicly disclosed information.

They were. All evidence before the Court demonstrates that the Relators’ knowledge of Exactech’s awareness of the Device’s defect was “direct and

independent” from the publicly disclosed information. Osheroff, 776 F.3d at 814. The independence of the Relators’ knowledge from the public disclosures is self- evident: Cory Watson only learned of Exactech’s awareness of the Device’s defect because the Relators told them.2 Likewise, all evidence before the Court

demonstrates that the Relators’ knowledge was direct: the Relators originally learned of Exactech’s awareness of the Device’s defect from meetings Relator

Fuentes personally attended where Exactech’s “top executives and engineers” met to discuss and strategize about “data demonstrating significant device failure.” (Doc. 1 at 7). This knowledge cannot be characterized as mere “background

information” enabling the Relators to “understand the significance of a more general public disclosure.” Osheroff, at 815.

The remainder of Exactech’s attempts to persuade this Court that the Relators were not the original sources of other information publicly disclosed through the Cory Watson lawsuits range from unmeritorious to completely

divorced from logic.3 The public-disclosure bar does not apply to this case. Exactech’s Motion for this Court to reconsider this holding is due to be DENIED.

2 Jon Conlin, lead attorney for Cory Watson in all five of the products-liability cases, swore under oath that the Relators were the first to tell his firm about Exactech’s definitive knowledge of the defect. (Doc. 169, Ex. A). Or in legal terms, Cory Watson itself identified the Relators as their original source of the information it publicly disclosed. In fact, the Relators brought this information to Cory Watson for the very purpose of seeking representation by that firm for this qui tam action. See (id.).

3 For example, Exactech argues that the fact that Relator Farley stated that Relator Fuentes had first-hand knowledge of the Devices’ widespread history of failures somehow demonstrates B. Whether the Device is “Reasonable and Necessary” Exactech’s second argument involves the Court’s conclusion that “the

evidence viewed in the light most favorable to Relators is sufficient to demonstrate a genuine issue of material fact exists as to whether the [Device] was ‘reasonable

and necessary.’” (Doc. 189 at 10 (citing Memorandum of Opinion, Doc. 184 at 22- 24)). As explained in this Court’s previous opinion, the “reasonable and necessary” determination in this case comes down to the failure rate of the Device.

(Memorandum Op., Doc. 184 at 22-24). Relators allege the failure rate is between 28 and 35%, and Exactech alleges the rate is less than 1%. (Id). In its Motion for Reconsideration, Exactech claims that “Relators’ own

evidence proves that the true failure rate is less than 1% . . . [b]ecause Relators have identified at most 292 [failures] . . . out of 33,927 Devices sold during the relevant period.” (Doc. 189 at 12) (emphasis added). Exactech reached that figure by

“divid[ing] the number of revisions by the total number of devices sold.” (Id. at 11) (emphasis added). There are two glaring issues with this argument. The first issue concerns the denominator Exactech used for their failure rate

calculation—the number of devices sold. Exactech provides no explanation for why

that Relator Farley lacks the same first-hand knowledge. By this logic, two persons could never have first-hand knowledge of the same event. Furthermore, Exactech fails to recognize that on the following page of Farley’s testimony, he specifically states that he too possessed first-hand knowledge. See (Doc. 169-5 at 4). it used this number when this case obviously concerns the number of Devices surgically implanted into human beings. Exactech’s argument only makes logical

sense by assuming that the number of devices sold is equal to the number of devices surgically implanted, or that there is some sort of technical definition of a medical

device’s failure rate that does not ignore medical devices sitting unused on storage shelves.4 Exactech has proffered neither argument nor evidence supporting either of these assumptions.

Free access — add to your briefcase to read the full text and ask questions with AI

United States of America v. Exactech Inc, (N.D. Ala. 2022).

United States of America v. Exactech Inc (United States of America v. Exactech Inc) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States Ex Rel. Osheroff v. Humana, Inc.
776 F.3d 805 (Eleventh Circuit, 2015)